Pasithea Therapeutics Corp. (NASDAQ:KTTA) ("Pasithea" or the "Company"), a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous system
Investor Group Sends Letter to Pasithea Therapeutics' Board of Directors
Urges the Company to Honor Stockholders' Will and Hold the Special Meeting Without Further Delay
Expresses Disappointment with the